Boston Scientific announces FDA approval Of ImageReady MRI

World |  News | 0 Comment | 22 Aug, 2019

Boston Scientific Corporation has announced the U.S. Food and Drug Administration (FDA) approval of its ImageReady™ MRI labeling for the Vercise Gevia™  Deep Brain Sti...Read more

Visiongain reports growth opportunities within the $424bn Generic Drugs market

World |  News | 0 Comment | 21 Aug, 2019

The generic drugs market is estimated to have reached $257.3bn in 2018 and is expected to grow at a CAGR of 8.8% in the first half of the forecast period. Asia-Pacific h...Read more

Pfizer Foundation invests $2M to tackle AMR

World |  News | 0 Comment | 21 Aug, 2019

The Pfizer Foundation has announced 20 grants to help non-governmental organizations (NGOs), non-profits and social enterprises address critical health challenges related to infectious dise...Read more

Global orphan drugs market at CAGR of 12% in Asia, Europe, NA, RoW

World |  News | 0 Comment | 21 Aug, 2019

Orphan drugs market analysis considers sales from both biologics and non-biologics. The analysis also considers the sales of orphan drugs in Asia, Europe, North America, and ...Read more

Global single-use filtration assemblies market to reach $7.0B by 2026 with a CAGR of 11.2%

World |  News | 0 Comment | 21 Aug, 2019

The global single-use filtration assemblies market size is expected to reach USD 7.0 billion by 2026 and is projected to exhibit a CAGR of 11.2%. The market is significantly drive...Read more

Global Molecular Imaging market to reach $11.13 billion by 2028

World |  News | 0 Comment | 21 Aug, 2019

As per the report, the global molecular imaging market analysis conducted by BIS Research, the market was valued at approximately $6.84 billion in 2018 and is anticipated to reach...Read more

AstraZeneca announces positive results for heart drug candidate

World |  News | 0 Comment | 20 Aug, 2019

AstraZeneca, on 20 August 2019, announced positive results from the landmark Phase III DAPA-HF trial which showed that Farxiga (dapagliflozin) met the primary composite endpo...Read more

FDA approves new antibiotic to treat community-acquired bacterial pneumonia

World |  News | 0 Comment | 20 Aug, 2019

The U.S. Food and Drug Administration, on 19 August 2019, approved Xenleta (lefamulin) to treat adults with community-acquired bacterial pneumonia. “This new drug provides another op...Read more

Moderna Receives FDA Fast Track Designation for Zika Vaccine

World |  News | 0 Comment | 20 Aug, 2019

Moderna, Inc.,a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, has annou...Read more

Microsoft welcomes new Chief Medical Officer Dr. David Rhew

World |  News | 0 Comment | 20 Aug, 2019

David Rhew, M.D., has joined Microsoft's Worldwide Commercial Business (WCB) Healthcare leadership team as the Chief Medical Officer and Vice President of Healthcare. David joined Microsof...Read more

Boston Scientific Closes Acquisition of BTG plc.

World |  News | 0 Comment | 20 Aug, 2019

Boston Scientific Corporation has announced the completion of its acquisition of BTG plc. pursuant to the previously announced scheme of arrangement. BTG develops and commercializes pr...Read more

Merck receives 7 additional CRISPR patents, bringing total to 20 worldwide

World |  News | 0 Comment | 20 Aug, 2019

Merck, a leading science and technology company, on 19th August 2019, announced that the European, Israeli, South Korean and U.K. intellectual property offices have issued formal notices al...Read more

IDTechEx forecasts $6.1 Billion market for 3D Printed Medical Devices 

World |  News | 0 Comment | 19 Aug, 2019

IDTechEx, a market intelligence and events company focused on emerging technologies, reports that the market for 3D printed medical devices and pharmaceuticals will be worth $6.1 billi...Read more

FDA approves novel treatment for highly drug-resistant forms of TB

World |  News | 0 Comment | 19 Aug, 2019

Pretomanid, a novel compound developed by the non-profit organization TB Alliance, was approved by the U.S. Food & Drug Administration (FDA), on 14 August 2019, for treating some of the...Read more

Medtronic Evolut TAVR System receives expanded indication

World |  News | 0 Comment | 19 Aug, 2019

 Medtronic has announced U.S. Food and Drug Administration (FDA) approval of the EvolutTM Transcatheter Aortic Valve Replacement (TAVR) system for patients with symptoma...Read more

FDA approves novel device to treat idiopathic scoliosis

World |  News | 0 Comment | 19 Aug, 2019

The U.S. Food and Drug Administration has approved the first spinal tether device intended to be used in children and adolescents to correct the most common form of scoliosis, called idiopa...Read more

FDA approves INREBIC for Myelofibrosis treatment

World |  News | 0 Comment | 19 Aug, 2019

Celgene Corporation has announced the U.S. Food and Drug Administration (FDA) has approved INREBIC® (fedratinib) for the treatment of adult patients with intermediate-2 or hig...Read more

AbbVie receives FDA approval for RINVOQ

World |  News | 0 Comment | 19 Aug, 2019

AbbVie,  a research-based global biopharmaceutical company, has announced that the U.S. Food and Drug Administration (FDA) has approved RINVOQ™ (upadacitinib), a 15 mg, once...Read more